Cantel Medical (CMD) Tops Q2 EPS by 4c
Get Alerts CMD Hot Sheet
Join SI Premium – FREE
Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.52, $0.04 better than the analyst estimate of $0.48. Revenue for the quarter came in at $184.82 million versus the consensus estimate of $188.04 million.
For earnings history and earnings-related data on Cantel Medical (CMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Capitol Federal Financial (CFFN) Misses Q2 EPS by 1c
- Biogen (BIIB) tops earnings expectations but revenue falls short
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!